IMMUNOCLOAK
DEAD

Serial Number

97822714

Owner

BREONICS Inc.

Attorney

Atul R. Singh

Filing Date

Mar 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOCLOAK Trademark

Serial Number: 97822714

IMMUNOCLOAK is a trademark filed by BREONICS Inc. on March 3, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BREONICS Inc. (4 trademarks)

44 Dalliba Avenue Suite 100
Watervliet, NY 12189

Entity Type: 03

Trademark Details

Filing Date

March 3, 2023

Registration Date

Not Registered

Published for Opposition

March 26, 2024

Goods & Services

Biochemical preparations for medical purposes, namely, bioengineered compounds for polymerized membranes to support organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered compounds for polymerized membranes for use in organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membranes to support organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in organ and tissue transplantation related applications; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition in organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membrane containing collagen, vitrogen, fibronectin and laminin for organ and tissue transplantation, bioengineering tissue constructs to replace allografts and manufacturing immunomodified organs; Biochemical preparations for medical purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft; Biochemical preparations for medical purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft to support organ and tissue transplantation

Biochemical preparations for scientific purposes, namely, bioengineered compounds for polymerized membranes to support organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered compounds for polymerized membranes for use in organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membranes to support organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in organ and tissue transplantation related applications; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition in organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membrane containing collagen, vitrogen, fibronectin and laminin; Biochemical preparations for scientific purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft; Biochemical preparations for scientific purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft to support organ and tissue transplantation

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 23, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 23, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 21, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2024 TROA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 16, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2024 REAP
NOTIFICATION OF PRIORITY ACTION E-MAILED
Dec 8, 2023 GPRN
PRIORITY ACTION E-MAILED
Dec 8, 2023 GPRA
PRIORITY ACTION WRITTEN
Dec 8, 2023 CPRA
ASSIGNED TO EXAMINER
Dec 1, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2023 NWOS